Table 2.
A summary of the ECM used on tumor chips.
Category | Gel condition | Concentration range | Advantages | Disadvantages | References |
---|---|---|---|---|---|
Rat tail collagen type I | At a neutral pH | 1.3–10.0 (mg/mL) | Similar to the ECM of tumors, biodegradability, containing cell adhesive domains, commercially available | Derived from animals, weak stability, monocomponent | [55,[149], [150], [151], [152], [153], [154], [155]] |
Matrigel | Above room temperature | 2.5%–10% (v/v) | A variety of protein components, biodegradability, commercially available | Derived from animals, undefined compositions, poor mechanical properties | [[156], [157], [158], [159], [160], [161]] |
Bovine fibrinogen | Mixed with bovine thrombin | 2.5–10.0 (mg/mL) | Promoting the self-assembly of HUVECs, enzymatical degradability, occurring RGD adhesion domains, commercially available | Risks of immunogen and pathogen, monocomponent | [56,140,[162], [163], [164], [165]] |
GelMA | Exposure to light with the assistance of a photoinitiator | 3%–10% (v/v) | Customized components, easy to pattern, rapid prototyping, good biocompatibility and bioactivity, commercially available | Risk of cell death induced by photoinitiators, lack of microscale pores to accommodate tumor cell migration, difficult to degrade | [133,156,166,167] |
Cultrex BME | Above room temperature | 2.5%–10% (v/v) | Similar to an early developmental basement membrane, commercially available | Risks of immunogen and pathogen, undefined compositions, poor mechanical properties | [[168], [169], [170]] |
dECM | Chemical, biological and physical methods | – | Reconstituted native ECM, customized components | Expensive cost, risk of cytotoxicity, require a different protocol to ensure efficient decellularization | [145,155] |